Two related studies reveal new risk indicators for prostate cancer. The first study shows that men diagnosed with benign prostate enlargement have an increased risk of developing and dying from prostate cancer. The second study shows that monitoring prostate-specific antigen levels can be used to predict the long-term risk of healthy men developing and dying from prostate cancer. Both could lead to more efficient and cost-effective screening for prostate cancer, with reductions in over-diagnosis and unnecessary treatment.
Read more detail in ScienceDaily:- Two new cost-effective ways to predict prostate cancer
No comments:
Post a Comment
Please be courteous and add your name rather than 'Anonymous' to your comment, as it may not be published. In the 'Comment as' box above use the drop-down menu and select 'Name/URL'. In the 'Edit profile' pop-up enter your name and press continue. There will be a period of delay before your comment appears on the article until I receive the automatic notification that you have made one and can authorised its publication.
Any comment that includes vulgar language, racist remarks or anything of that nature will either be edited or not published at my discretion.